21 July 2024 : Clinical Research
Cost-Effectiveness Analysis of Hepatic Arterial Chemotherapy for Advanced Hepatocellular Carcinoma in China: A Comparative Analysis of HAIC-FO and Sorafenib
Jie Gao1BCE, Shu Liu2BCE, Shao-Jun Li1BCE, Rui Wang3E, Zeng-Hui Meng1AE, Xiang-Shuo Kong2AE*DOI: 10.12659/MSM.944526
Med Sci Monit 2024; 30:e944526
Figure 4 The cost-effectiveness acceptability curve. HAIC-FO – hepatic arterial infusion chemotherapy with infusional fluorouracil, leucovorin, and oxaliplatin.